Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02927249
Recruitment Status : Recruiting
First Posted : October 7, 2016
Last Update Posted : February 5, 2020
National Cancer Institute (NCI)
United States Department of Defense
Canadian Cancer Trials Group
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2021
Study Completion Date : No date given